Chronic B-cell leukemia with potentially functional biallelic Vλ-Jλ rearrangements as determined by Southern blotting
| Patient . | Vλ . | Junctional region5-150 . | Jλ . | Frame5-151 . | RT-PCR5-152 . | Somatic mutations5-153 . | ||
|---|---|---|---|---|---|---|---|---|
| 4 | Vλ1-44 | 0 | G | −1 | Jλ3 | + | + | + |
| Vλ2-55-155 | −4 | TGG | −1 | Jλ3 | − | + | + | |
| 20 | Vλ1-40 | −4 | TCTA | 0 | Jλ3 | + | + | + |
| Vλ3-12 | 0 | − | −3 | Jλ3 | + | + | + | |
| 21 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | ND | − |
| Vλ1-47 | 0 | A | 0 | Jλ3 | − | ND | − | |
| 22 | Vλ2-11 | −15 | 26 nt of Vλ2-14 | −7 | Jλ3 | + | + | + |
| Vλ1-47 | −4 | C | 0 | Jλ3 | + | + | + | |
| 23 | Vλ1-40 | −2 | CGAG | −2 | Jλ3 | + | + | − |
| Vλ3-21 | −2 | − | −2 | Jλ3 | − | + | − | |
| 24 | Vλ3-21 | 0 | CCCT | −1 | Jλ3 | + | + | − |
| Vλ2-55-155 | −4 | − | −1 | Jλ2 | (+)5-155 | + | − | |
| 25 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | ND | − |
| Vλ1-51 | −11 | CCC | 0 | Jλ3 | − | ND | − | |
| 26 | Vλ1-40 | −5 | AG | 0 | Jλ3 | + | ND | + |
| Vλ3-10 | −6 | GGGA | −4 | Jλ1 | − | ND | + | |
| 27 | Vλ3-21 | 0 | − | Jλ3 | + | + | − | |
| NI | Jλ35-154 | NI | NI | |||||
| 28 | Vλ2-18 | −3 | GGT | 0 | Jλ1 | + | + | + |
| Vλ4-60 | −2 | − | −1 | Jλ3 | + | + | + | |
| 29 | Vλ2-11 | −3 | CA | −3 | Jλ3 | + | + | + |
| Vλ1-44 | −2 | − | 0 | Jλ3 | + | + | − | |
| 30 | Vλ2-14 | −3 | GG | −3 | Jλ1 | + | + | + |
| NI | Jλ35-154 | NI | NI | |||||
| 31 | Vλ1-47 | −6 | − | −3 | Jλ3 | + | + | − |
| NI | Jλ25-154 | NI | NI | |||||
| 32 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | + | + |
| Vλ1-47 | −2 | − | −1 | Jλ3 | + | + | + | |
| Patient . | Vλ . | Junctional region5-150 . | Jλ . | Frame5-151 . | RT-PCR5-152 . | Somatic mutations5-153 . | ||
|---|---|---|---|---|---|---|---|---|
| 4 | Vλ1-44 | 0 | G | −1 | Jλ3 | + | + | + |
| Vλ2-55-155 | −4 | TGG | −1 | Jλ3 | − | + | + | |
| 20 | Vλ1-40 | −4 | TCTA | 0 | Jλ3 | + | + | + |
| Vλ3-12 | 0 | − | −3 | Jλ3 | + | + | + | |
| 21 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | ND | − |
| Vλ1-47 | 0 | A | 0 | Jλ3 | − | ND | − | |
| 22 | Vλ2-11 | −15 | 26 nt of Vλ2-14 | −7 | Jλ3 | + | + | + |
| Vλ1-47 | −4 | C | 0 | Jλ3 | + | + | + | |
| 23 | Vλ1-40 | −2 | CGAG | −2 | Jλ3 | + | + | − |
| Vλ3-21 | −2 | − | −2 | Jλ3 | − | + | − | |
| 24 | Vλ3-21 | 0 | CCCT | −1 | Jλ3 | + | + | − |
| Vλ2-55-155 | −4 | − | −1 | Jλ2 | (+)5-155 | + | − | |
| 25 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | ND | − |
| Vλ1-51 | −11 | CCC | 0 | Jλ3 | − | ND | − | |
| 26 | Vλ1-40 | −5 | AG | 0 | Jλ3 | + | ND | + |
| Vλ3-10 | −6 | GGGA | −4 | Jλ1 | − | ND | + | |
| 27 | Vλ3-21 | 0 | − | Jλ3 | + | + | − | |
| NI | Jλ35-154 | NI | NI | |||||
| 28 | Vλ2-18 | −3 | GGT | 0 | Jλ1 | + | + | + |
| Vλ4-60 | −2 | − | −1 | Jλ3 | + | + | + | |
| 29 | Vλ2-11 | −3 | CA | −3 | Jλ3 | + | + | + |
| Vλ1-44 | −2 | − | 0 | Jλ3 | + | + | − | |
| 30 | Vλ2-14 | −3 | GG | −3 | Jλ1 | + | + | + |
| NI | Jλ35-154 | NI | NI | |||||
| 31 | Vλ1-47 | −6 | − | −3 | Jλ3 | + | + | − |
| NI | Jλ25-154 | NI | NI | |||||
| 32 | Vλ3-21 | 0 | − | 0 | Jλ3 | + | + | + |
| Vλ1-47 | −2 | − | −1 | Jλ3 | + | + | + | |
RT-PCR indicates reverse transcriptase–polymerase chain reaction.
The junctional region is described as the number of bases lost at the 3′ end of the V segment followed by randomly inserted nucleotides and the number of bases lost from the 5′ end of the J segment.
Frame of the junctional region: +, in-frame, without stop codons in the junctional region; −, out-of-frame.
ND, not determined; NI, not identified; +, present; −, absent.
+ indicates V segments with more than 2% somatic mutations; −, less than 2% somatic mutations; NI, not identified, because the rearrangement could not be amplified.
Vλ2-5 is a pseudogene and, therefore, not functional.
Based on Southern blot data.